ADORA2b Signaling in Cardioprotection.

Area of Science:

• Cardiovascular Research
• Molecular Cardiology
• Ischemic Preconditioning

Background:

• Cardiovascular disease is a leading global cause of death.
• Ischemic preconditioning (IP) offers cardioprotection by mimicking short ischemia/reperfusion episodes.
• Adenosine and its receptors are implicated in IP-mediated cardioprotection.

Purpose of the Study:

• To identify novel molecular targets that mimic ischemic preconditioning (IP) for cardioprotection.
• To investigate the role of adenosine receptors, specifically ADORA2b, in cardiac IP.
• To explore downstream targets of ADORA2b involved in IP-mediated cardioprotection.

Main Methods:

• Utilized genetic studies and tissue-specific mice to investigate ADORA2b function in cardiac IP.
• Performed a comprehensive search for ADORA2b downstream targets.
• Conducted mechanistic studies on the identified target, Period 2 (PER2), in cardioprotection.

Main Results:

• Adenosine receptor 2B (ADORA2b) plays a crucial role in cardiac IP in both human and murine models.
• Cardiomyocytes and endothelial cells were identified as key cell types mediating cardiac IP via ADORA2b.
• The circadian rhythm protein Period 2 (PER2) was identified as a novel downstream target of ADORA2b, crucial for IP-mediated cardioprotection.
• PER2 optimizes cardiac metabolism by activating oxygen-saving pathways.

Conclusions:

• ADORA2b expressed in cardiomyocytes or endothelial cells is a key target for cardiac IP.
• The circadian rhythm protein PER2 is a novel mediator of IP-induced cardioprotection.
• Targeting ADORA2b or PER2 presents potential novel therapeutic strategies for preventing or treating myocardial infarction (MI).